What the state is buying
by RFPFinder from the notice and attachments; the solicitation governsThe North Carolina Department of Health and Human Services is purchasing opioid antagonist medications and related ancillary services. This is an Agency Specific Contract, and proposals will be evaluated based on unknown criteria.
Scope
- Purchase and shipping of intranasal and intramuscular opioid antagonist medications.
- Ancillary services related to the distribution and use of these medications.
From USAspending awards and the notice text, recomputed nightly (Oct 7). A signal, not a verdict.
How to get the bid documents
- Download the 3 documents below (no portal account needed)
- Check the submission requirements in the compliance checklist
- Submit through NC Division of Purchase & Contract - Electronic Vendor Portal (eVP) (free account) before 10:00 AM ET on Oct 23
To submit, you need a free account at NC Division of Purchase & Contract - Electronic Vendor Portal (eVP).
Details
- Place of performance
- North Carolina
- Buyer type
- State
- Notice type
- RFP
- Solicitation no.
- Doc2397329843
- Category
- Supplies & Equipment
- Delivery location
- North Carolina from notice
- Period of performance
- 1-year base + 3 one-year options from attachment p.7
- Contract type
- Agency Specific Contract from attachment p.7
- Evaluation
- Sealed bid, price only (FAR 14) from attachment
- Local presence
- Required
- Amendments
- None since Sep 29
- Contact
- Katherine Hens
Not stated in the notice: estimated value. Check the bid documents.
Contact details from the source notice. Contact the buyer only about this solicitation.
Key dates
Change log
verified Wed, Oct 7 · 2:17 PM ETNo amendments since posting on Tue, Sep 29; verified Wed, Oct 7 · 2:17 PM ET.
Report a problem
Notice as published
30-270064-DMH_Opioid Antagonist
The purpose of this Request for Proposal (RFP) is to obtain a Vendor(s) to partner with the North Carolina Department of Health and Human Services (NCDHHS), Division of Mental Health, Developmental Disabilities and Substance Use Services (DMH/DD/SUS or “Division”) for the purchase and shipping of opioid antagonist medications within the State of North Carolina.From 2000-2024, more than 44,500 North Carolinians lost their lives to a drug overdose. Each day in 2024, 8 North Carolinians died from a drug overdose. Recent year death data is not yet final, but an estimated 2,731 North Carolinians (8 per day) are suspected to have died from an overdose in 2025.An opioid antagonist is a medication that binds to opioid receptors in the brain and blocks or reverses the effects of opioids such as heroin, fentanyl, oxycodone, morphine, and hydrocodone.
It works quickly to restore normal breathing in someone experiencing an opioid overdose, which can prevent brain damage or death.The General Assembly of North Carolina, Session 2025, enacted Session Law 2026-41, Senate Bill 257. Section IX-G, Mental Health/Developmental Disabilities/Substance Use Services, Use of Opioid Settlement Funds which outlines the procurement of the following directly from drug manufacturers:a. Intranasal and intramuscular opioid antagonists for distribution to, or use by, persons or governmental entities engaged in opioid overdose prevention and response efforts within the State of North Carolina.b.
Ancillary services related to the distribution and use of intranasal and intramuscular opioid
Listing collected from NC Division of Purchase & Contract - Electronic Vendor Portal (eVP). Always confirm requirements in the original solicitation before you bid.